PHARMACOGENETIC MARKERS FOR SUSCEPTIBILITY TO DRUG-INDUCED PANCREATIC TOXICITY

摘要

The present invention is directed to methods for identifying patients at increased risk for experiencing drug-induced pancreatic toxicity and involves analyzing certain single nucleotide polymorphisms in the patient. The invention also encompasses kits containing oligonucleotides that can be used in this analysis.